Nova Ltd Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $880.6M+31.0% YoYTTM through 31 Dec 2025
Net Income $259.2M+41.1% YoYTTM through 31 Dec 2025
Free Cash Flow $217.9MTTM through 31 Dec 2025
Margins
| Current | |
|---|---|
| Gross Margin | 57.7% |
| EBITDA Margin | 29.4% |
| Operating Margin | 30.1% |
| Net Margin | 29.4% |
Returns
19.0%ROE
11.5%ROA
14.1%ROIC
Balance Sheet Health
Debt / Equity0.53x
Current Ratio1.58x
Net Debt-$580.3Mnet cash position
Cash & Equivalents$214.5M
Quality Metrics
Altman Z-Score8.73
Piotroski F-Score3 / 9
FCF Margin24.7%
Rule of 4047.1
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $880.6M
Diluted EPS$7.96TTMFY2025: $7.96
Dividend
No dividend
Capital Allocation
R&D Spend$143.4M
Capex Intensity3.1%
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.